Literature DB >> 2112369

Properties of a novel nitric oxide-stimulated ADP-ribosyltransferase.

B Brüne1, E G Lapetina.   

Abstract

A novel ADP-ribosyltransferase is present in the cytosolic fraction of various cells. The kinetic behavior and physical properties of this enzyme's activity are clearly distinguished from other known cytosolic ADP-ribosyltransferases. Agents that release nitric oxide, such as sodium nitroprusside, greatly stimulated this activity, although this effect was dependent on the presence of intact thiol groups. Dithiothreitol, reduced glutathione, or cysteine was needed for activation of the enzyme, while N-ethylmaleimide inhibited enzyme activity. High concentrations of phosphate had a slight stimulatory effect, while high concentrations of sodium chloride and thiocyanate were inhibitory. ATP also inhibited this activity. This cytosolic ADP-ribosyltransferase is clearly distinguished from other known and characterized cytosolic transferases. Its activation by biologically active nitric oxide suggests an important role for this enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112369     DOI: 10.1016/0003-9861(90)90493-i

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Nitric oxide inhibits viral replication in murine myocarditis.

Authors:  C J Lowenstein; S L Hill; A Lafond-Walker; J Wu; G Allen; M Landavere; N R Rose; A Herskowitz
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

2.  Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme.

Authors:  V Pancholi; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  Regulation of platelet granule exocytosis by S-nitrosylation.

Authors:  Craig N Morrell; Kenji Matsushita; Kelly Chiles; Robert B Scharpf; Munekazu Yamakuchi; Rebecca J A Mason; Wolfgang Bergmeier; Joseph L Mankowski; William M Baldwin; Nauder Faraday; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

4.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

5.  Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase.

Authors:  L J McDonald; J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages.

Authors:  C Pellat-Deceunynck; J Wietzerbin; J C Drapier
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

7.  Failure of [32P]ADP-ribosylation by pertussis toxin to determine Gi alpha content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducin.

Authors:  M Böhm; K Larisch; E Erdmann; M Camps; K Jakobs; P Gierschik
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

8.  An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation.

Authors:  E M Schuman; M K Meffert; H Schulman; D V Madison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 9.  Nitric oxide and NAD-dependent protein modification.

Authors:  L J McDonald; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

10.  The purification of a cysteine-dependent NAD+ glycohydrolase activity from bovine erythrocytes and evidence that it exhibits a novel ADP-ribosyltransferase activity.

Authors:  B A Saxty; S van Heyningen
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.